Innovation Pharmaceuticals Inc.
IPIX
$0.00
$0.0012.50%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -2.62M | -3.17M | -4.11M | -4.90M | -6.41M |
| Total Depreciation and Amortization | 374.00K | 373.00K | 376.00K | 378.00K | 380.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 237.00K | 379.00K | 811.00K | 975.00K | 920.00K |
| Change in Net Operating Assets | 17.00K | 310.00K | 231.00K | 201.00K | -4.00K |
| Cash from Operations | -1.99M | -2.11M | -2.70M | -3.35M | -5.12M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.00K | -60.00K | -4.08M | -4.07M | -4.07M |
| Cash from Investing | -58.00K | -60.00K | -4.08M | -4.07M | -4.07M |
| Total Debt Issued | 25.00K | -- | -- | -- | -- |
| Total Debt Repaid | -31.00K | -37.00K | -12.00K | -15.00K | -1.04M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 23.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 2.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -48.00K | -86.00K | -70.00K | -70.00K | -38.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.00K | -123.00K | -82.00K | -85.00K | 946.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.10M | -2.29M | -6.86M | -7.50M | -8.24M |